Literature DB >> 30797794

Hepatitis C Virus Infection in Patients With Cancer: Impact on Clinical Trial Enrollment, Selection of Therapy, and Prognosis.

Harrys A Torres1, Pooja Pundhir1, Vincent Mallet2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30797794     DOI: 10.1053/j.gastro.2019.01.271

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  7 in total

1.  Latent infection screening and prevalence in cancer patients born outside of Australia: a universal versus risk-based approach?

Authors:  Gemma Reynolds; Gabrielle Haeusler; Monica A Slavin; Benjamin Teh; Karin Thursky
Journal:  Support Care Cancer       Date:  2021-03-24       Impact factor: 3.603

Review 2.  Safety of direct acting antiviral treatment for hepatitis C in oncologic setting: A clinical experience and a literature review.

Authors:  Anna Maria Spera
Journal:  World J Hepatol       Date:  2022-03-27

3.  Hepatitis B virus reactivation in cancer patients receiving direct-acting antivirals for hepatitis C virus infection.

Authors:  Haley Pritchard; Jessica P Hwang; Georgios Angelidakis; Marcel Yibirin; Lan Wang; Ethan Miller; Harrys A Torres
Journal:  J Viral Hepat       Date:  2021-02-10       Impact factor: 3.728

Review 4.  Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy.

Authors:  Dimitrios C Ziogas; Frosso Kostantinou; Evangelos Cholongitas; Amalia Anastasopoulou; Panagiotis Diamantopoulos; John Haanen; Helen Gogas
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

5.  Successful treatment by on-demand glecaprevir and pibrentasvir for hepatitis C flare during R-CHOP in patients with diffuse large B-cell lymphoma: a case report.

Authors:  Machiko Umemura; Goki Suda; Shihori Tsukamoto; Ko Ebata; Shinjiro Takahash; Takashi Sasaki; Sae Nakajima; Koji Hirata; Mariko Ozasa; Masatoshi Takano; Masaki Katagiri; Naoya Sakamoto
Journal:  BMC Infect Dis       Date:  2021-04-27       Impact factor: 3.090

6.  Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies.

Authors:  Harrys A Torres; Georgios Angelidakis; Ying Jiang; Minas Economides; Khalis Mustafayev; Marcel Yibirin; Robert Orlowski; Richard Champlin; Srdan Verstovsek; Issam Raad
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

7.  Salvage therapy in cancer patients with hepatitis C without sustained virologic response after direct-acting antivirals-A prospective study.

Authors:  Haley Pritchard; Deeksha Jandhyala; Jeff Hosry; Georgios Angelidakis; Harrys A Torres
Journal:  JGH Open       Date:  2019-12-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.